Due to its rapid growth and potential to add to the respiratory virus burden in Northern Hemisphere countries, the World Health Organization (WHO) today designated JN.1, part of the BA.2.86 SARS-CoV-2 lineage, as its own variant of interest.
The announcement came following an assessment from the WHO’s Technical Advisory Group on SARS-CoV-2 evolution.
Comments closed